Allo-HLA reactivity of virus-specific memory T cells is common AL Amir, LJA D'Orsogna, DL Roelen, MM van Loenen, RS Hagedoorn, ... Blood, The Journal of the American Society of Hematology 115 (15), 3146-3157, 2010 | 334 | 2010 |
Mixed T cell receptor dimers harbor potentially harmful neoreactivity MM van Loenen, R de Boer, AL Amir, RS Hagedoorn, GL Volbeda, ... Proceedings of the National Academy of Sciences 107 (24), 10972-10977, 2010 | 279 | 2010 |
PRAME-specific allo-HLA–restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer AL Amir, DM van der Steen, MM van Loenen, RS Hagedoorn, R de Boer, ... Clinical Cancer Research 17 (17), 5615-5625, 2011 | 152 | 2011 |
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up JH van den Berg, B Heemskerk, N van Rooij, R Gomez-Eerland, ... Journal for immunotherapy of cancer 8 (2), 2020 | 114 | 2020 |
Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment I de Weerdt, T Hofland, R de Boer, JA Dobber, J Dubois, ... Blood advances 3 (17), 2642-2652, 2019 | 101 | 2019 |
Eerste evaluatie Jeugdwet: Na de transitie nu de transformatie RD Friele, MR Bruning, ILW Bastiaanssen, R De Boer, A Bucx, ... ZonMw, 2018 | 63 | 2018 |
The molecular bases of δ/αβ T cell–mediated antigen recognition DG Pellicci, AP Uldrich, J Le Nours, F Ross, E Chabrol, SBG Eckle, ... Journal of Experimental Medicine 211 (13), 2599-2615, 2014 | 62 | 2014 |
Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells H Jolink, R de Boer, P Hombrink, RE Jonkers, JT van Dissel, ... Journal of Infection 74 (1), 81-88, 2017 | 55 | 2017 |
A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells MM van Loenen, R de Boer, E van Liempt, P Meij, I Jedema, ... Haematologica 99 (4), 759, 2014 | 50 | 2014 |
Optimization of the HA-1-specific T-cell receptor for gene therapy of hematologic malignancies MM van Loenen, R de Boer, RS Hagedoorn, EHM van Egmond, ... Haematologica 96 (3), 477, 2011 | 50 | 2011 |
Mixed functional characteristics correlating with TCR‐ligand koff‐rate of MHC‐tetramer reactive T cells within the naive T‐cell repertoire P Hombrink, Y Raz, MGD Kester, R de Boer, B Weißbrich, ... European journal of immunology 43 (11), 3038-3050, 2013 | 44 | 2013 |
A bispecific single-domain antibody boosts autologous Vγ9Vδ2-T cell responses toward CD1d in chronic lymphocytic leukemia I de Weerdt, R Lameris, JM Ruben, R de Boer, J Kloosterman, LA King, ... Clinical Cancer Research 27 (6), 1744-1755, 2021 | 32 | 2021 |
HA-1H T-cell receptor gene transfer to redirect virus-specific T cells for treatment of hematological malignancies after allogeneic stem cell transplantation: a phase 1 … P van Balen, I Jedema, MM van Loenen, R de Boer, HM van Egmond, ... Frontiers in Immunology 11, 1804, 2020 | 26 | 2020 |
Identification of varicella-zoster virus-specific CD8 T cells in patients after T-cell-depleted allogeneic stem cell transplantation PLJ van der Heiden, R de Boer, DM van der Steen, MGD Kester, ... Journal of virology 83 (14), 7361-7364, 2009 | 26 | 2009 |
Multi-cistronic vector encoding optimized safety switch for adoptive therapy with T-cell receptor-modified T cells MM Van Loenen, R De Boer, RS Hagedoorn, V Jankipersadsing, AL Amir, ... Gene therapy 20 (8), 861-867, 2013 | 25 | 2013 |
A bispecific antibody antagonizes prosurvival CD40 signaling and promotes Vγ9Vδ2 T cell–mediated antitumor responses in human B-cell malignancies I de Weerdt, R Lameris, GL Scheffer, J Vree, R de Boer, AG Stam, ... Cancer immunology research 9 (1), 50-61, 2021 | 24 | 2021 |
T helper 2 response in allergic bronchopulmonary aspergillosis is not driven by specific Aspergillus antigens H Jolink, R De Boer, LNA Willems, JT Van Dissel, JHF Falkenburg, ... Allergy 70 (10), 1336-1339, 2015 | 22 | 2015 |
Elevated folate levels in amniotic fluid after oral supplementation RPM Steegers-Theunissen, EAP Steegers, R De Boer, CMG Thomas, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 36 (3 …, 1990 | 22 | 1990 |
Natural killer cell hypo-responsiveness in chronic lymphocytic leukemia can be circumvented in vitro by adequate activating signaling T Hofland, S Endstra, CKP Gomes, R De Boer, I De Weerdt, V Bobkov, ... Hemasphere 3 (6), e308, 2019 | 21 | 2019 |
Dissection of the effects of JAK and BTK inhibitors on the functionality of healthy and malignant lymphocytes T Hofland, I de Weerdt, H Ter Burg, R de Boer, S Tannheimer, SH Tonino, ... The Journal of Immunology 203 (8), 2100-2109, 2019 | 19 | 2019 |